Four-year follow-up of mycophenolate mofetil for graft rescue in liver allograft recipients

Transplantation

Volumn 67, Issue 5, 1999, Pages 707-712

  Hebert, Mary F ^a   Ascher, Nancy L ^b   Lake, John R ^c   Emond, Jean ^d   Nikolai, Bev ^b   Linna, T Juhani ^e   Roberts, John P ^b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

^d NEW YORK PRESBYTERIAN HOSPITAL   (United States)

^e ROCHE BIOSCIENCE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN A; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE;

ADULT; AGED; ALLOGRAFT; ANEMIA; ARTICLE; BONE MARROW SUPPRESSION; CLINICAL ARTICLE; CLINICAL TRIAL; DIARRHEA; DUODENITIS; ESOPHAGITIS; FEMALE; FOLLOW UP; GASTRITIS; GASTROINTESTINAL SYMPTOM; GRAFT REJECTION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LEUKOPENIA; LIVER TRANSPLANTATION; MALE; NAUSEA; PILOT STUDY; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; THROMBOCYTOPENIA; VOMITING;

EID: 0033558914     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199903150-00011     Document Type: Article

References (12)

1. Lee WA, Gu L, Miksztal AR, Chu N, Leung K, Nelson PH. Bioavailability improvement of mycophenolic acid through amino ester derivatization. Pharm Res 1990; 7: 161.
2. Klintmalm GB, Ascher NL, Busuttil RW, et al. RS-61443 for treatment-resistant human liver rejection. Transplant Proc 1993; 25: 697.
3. Gavlik A, Goldberg MG, Tsaroucha A, et al. Mycophenolate mofetil rescue therapy in liver transplant recipients. Transplant Proc 1997; 29: 549.
4. Klupp J, Bechstein WO, Platz KP, et al. Mycophenolate mofetil added to immunosuppression after liver transplantation: first results. Transpl Int 1997; 10: 223.
5. Snover DC, Freese DK, Sharp HL, Bloomer JR, Najarian JS, Ascher NL. Liver allograft rejection: an analysis of the use of biopsy in determining outcome of rejection. Am J Surg Pathol 1987; 11: 1.
6. Roberts JP, Lake JR, Hebert M, Nikolai B, Ascher NL, Ferrell LD. Reversal of chronic rejection after treatment failure with FK506 and RS61443. Transplantation 1993; 56: 1021.
7. Hebert MF, Ascher NL, Lake JR, Roberts JP. Efficacy and toxicity of FK 506 for the treatment of resistant rejection in liver transplant patients. Transplant Proc 1991; 23: 3109.
8. Starzl TE, Todo S, Fung J, Demetris AJ, Venkataramanan R, Jain A. FK 506 for liver, kidney and pancreas transplantation. Lancet 1989; 2: 1000.
9. Klintmalm GB, Gibbs JF, McMillan R, et al. Rejection: FK 506 for rescue or maintenance. Transplant Proc 1993; 25: 1914.
10. Woodle ES, Perdrizet GA, So SK, Shite HM, Marsh JW. FK 506 rescue therapy for hepatic allograft rejection: experience with an aggressive approach. Clin Transplant 1995; 9: 45.
11. The U.S. Multicenter FK506 Liver Study Group. A comparison of tacrolimus (FK 506) and cyclosporine for immunosuppression in liver transplantation. N Engl J Med 1994; 331: 1110.
12. Starzl TE. New approaches in the use of cyclosporine with particular reference to the liver. Transplant Proc 1988; 20: 356.